YARS1 and Alzheimer disease: Despite differential effects on TyrRS levels (Figure S2B), both cis‐ and trans‐RSV significantly increased the mRNA levels of TyrRS in hESC‐derived neurons (1.5 and 2.8‐fold, respectively, data not shown), supporting the report that AD brains exhibit strong proteomic disease‐related changes not observed at the RNA level [75].